- Home
- CHKP vs SNN Comparison
CHKP vs SNN Comparison
Compare CHKP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHKP | SNN |
|---|---|---|
| Founded | 1993 | 1856 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.3B |
| IPO Year | 1997 | 2002 |
Fundamental Metrics
Financial Performance| Metric | CHKP | SNN |
|---|---|---|
| Price | $139.62 | $30.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 38 | 6 |
| Target Price | ★ $152.15 | $32.32 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 11-02-2026 | 08-04-2026 |
| Dividend Yield | N/A | ★ 2.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.87 | $4.75 |
| Revenue Next Year | $5.21 | $5.15 |
| P/E Ratio | ★ $17.05 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $112.23 | $26.30 |
| 52 Week High | $206.43 | $37.09 |
Technical Indicators
Market Signals| Indicator | CHKP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 61.82 |
| Support Level | $134.13 | $29.18 |
| Resistance Level | $151.85 | $30.52 |
| Average True Range (ATR) | 5.49 | 0.47 |
| MACD | -0.68 | 0.08 |
| Stochastic Oscillator | 23.40 | 62.64 |
Price Performance
Historical ComparisonAbout CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.